NEONC TECHNOLOGIES HOLDINGS, INC.
Developing intranasal drug delivery to treat brain cancer & CNS diseases by crossing the BBB.
NTHI | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 23975 PARK SORRENTO, 91302 CALABASAS
- Website:
- https://neonc.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company developing treatments for Central Nervous System (CNS) diseases, particularly brain cancers like glioblastoma. The company's core is a proprietary, patented platform technology featuring a novel intranasal drug delivery system designed to overcome the Blood-Brain Barrier (BBB). This technology facilitates the direct transport of new and established therapeutics to the brain, enhancing their potential efficacy. The company's pipeline includes candidates such as NEO100 and NEO212. NeOnc's platform offers a pathway for pharmaceutical companies to develop more effective treatments for challenging neurological conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NEONC TECHNOLOGIES HOLDINGS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NEONC TECHNOLOGIES HOLDINGS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NEONC TECHNOLOGIES HOLDINGS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
